The Worlds #1 Renewable Energy Network for News & Information
Sign In
or
Register
Sections
Home
Solar
Wind
Geothermal
Bio
Hydro
Careers
Companies
Webcasts
White Papers
Magazines
Awards
Account
Sign In
Register
Search
REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Bristol-Myers Squibb Co.
(NY:
BMY
)
46.40
USD
UNCHANGED
Official Closing Price
/ Updated:
6:40 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Bristol-Myers Squibb Co.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
A Look Ahead: This Week's ETFs to Watch
April 28, 2013
Last week was another fine one for U.S. stocks as the broader market fought off an array of data points that can only be considered mixed at best to again close higher. With last week's 1.4 percent...
Read More
category
Earnings
,
Specialty ETFs
,
Emerging Market ETFs
, and 24 more.
from
Latest Articles from Benzinga.com
'Utterly Absurd' Stock Rally: Josh Brown
April 26, 2013
A pullback would be healthy for the stock market - and may be overdue, Josh Brown of Fusion Analytics says.
Read More
category
tvfmwebex
,
Bristol/Myers Squibb Co
,
Amgen Inc
, and 9 more.
from
CNBC.com News
Bristol-Myers Squibb’s New Drugs Can Help Reverse Its Sinking Revenue
April 26, 2013
category
Pharmaceuticals
,
Unassigned
from
Trefis
Short Sellers Move into Celgene, Regeneron
April 26, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 34 more.
from
Latest Articles from Benzinga.com
UPDATE 3-AbbVie delivers on strong growth of Humira arthritis drug
April 26, 2013
April 26 (Reuters) - AbbVie Inc's quarterly profit rose 10 percent on surging sales of its Humira treatment for rheumatoid arthritis, and the company said it plans to launch several potentially...
Read More
category
companyNews
from
Reuters: Company News
4 Pharmaceutical Stocks to Buy Now
April 26, 2013
Read More
category
NYSE:JNJ
,
NYSE:WPI
,
Stocks to Buy
, and 2 more.
from
InvestorPlace - Latest Headlines
Next Support Level for Bristol-Myers Squibb (BMY) is $39.51
April 26, 2013
from
Comtex SmarTrend® News Briefs
Stocks Survive Once Again
April 25, 2013
Today's financial recap and tomorrow's financial outlook.
Read More
category
AMZN
,
QCOM
,
AAPL
, and 2 more.
from
Minyanville Headlines
Dividend Highlights/Lowlights for April 25
April 25, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights Dow Chemical (DOW) – up 6% Royal Caribbean Cruises Ltd. (RCL) – up 5% Las...
Read More
category
bmy
,
fl
,
rcl
, and 10 more.
from
Dividend Daily
Bristol-Myers Squibb Co. Becomes #168 Most Shorted S&P 500 Component, Replacing Allegheny Technologies, Inc
April 25, 2013
The most recent short interest data has been released by the NASDAQ for the 04/15/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying...
Read More
category
Stocks
from
Market News Video
UPDATE 3-Bristol-Myers Squibb sales disappoint, shares fall
April 25, 2013
April 25 (Reuters) - Bristol-Myers Squibb reported disappointing first-quarter sales, prompting a drop in shares that have risen sharply this year on enthusiasm for its lineup of promising experimental...
Read More
category
companyNews
from
Reuters: Company News
Bristol Myers Profit Declines on Expired Patents; Matches Earnings Estimates (BMY)
April 25, 2013
Biopharmaceutical company, Bristol Myers Squibb Co. (BMY) saw a decline in earnings on Thursday, caused by the loss of sales from expired patents. Still, the company matched analysts earnings estimates...
Read More
category
bmy
,
Bristol Myers Squibb Co/
,
Dividend Stocks
from
Dividend Daily
Bearish Moving Average Cross by Bristol-Myers Squibb (BMY)
April 25, 2013
from
Comtex SmarTrend® News Briefs
Updates, advisories and surprises
April 25, 2013
A roundup of the latest corporate earnings reports and what companies are saying about future quarters.
Read More
category
SOX
,
Earnings
,
ZNGA
, and 16 more.
from
MarketWatch
StreetInsider.com Pre-Open Movers 4/25: (AKAM) (INFN) (FIO) Higher; (XIDE) (INTU) (CTXS) Lower (more...)
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8278305 for the full story.
Read More
from
StreetInsider.com News Articles
US STOCKS-Futures climb as earnings roll in; claims data on tap
April 25, 2013
NEW YORK, April 25 (Reuters) - U.S. stock index futures advanced on Thursday, as investors dealt with a raft of earnings, including those of 3M Co, along with data on the labor market.
Read More
category
companyNews
from
Reuters: Company News
Bristol-Myers Squibb Co. (BMY) Reports In-Line Q1 EPS; Reaffirms
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8277421 for the full story.
Read More
from
StreetInsider.com News Articles
Stock futures up ahead of Dow Chemical, claims
April 25, 2013
U.S. stock market futures rise ahead of Wall Street’s open on Thursday, against a backdrop of mixed global markets, as investors look ahead to earnings from Dow Chemical and Exxon Mobil and weekly...
Read More
category
Earnings
,
VZ
,
UL
, and 37 more.
from
MarketWatch
Amazon, Starbucks, UPS are stocks to watch
April 25, 2013
Amazon.com, Starbucks, and United Parcel Service are among the stocks likely to be active on Thursday as the earnings parade continues.
Read More
category
TWC
,
Earnings
,
CSTR
, and 46 more.
from
MarketWatch
US Stocks Seen Up Ahead of Earnings Blitz
April 25, 2013
U.S. stock index futures signaled a higher open early on Thursday, as investors await the busiest day of the earnings season, with reports from the likes of Amazon, Starbucks and Dow component 3M.
Read More
category
ASTRAZENECA PLC
,
Investing/Bonds
,
Dow Chemical Co
, and 20 more.
from
CNBC.com News
Cramer: Sellers Clobbering Stocks Recklessly?
April 24, 2013
Pockets of weakness in the market have captured Jim Cramer's attention. Is the selling really warranted?
Read More
category
Biotechnology
,
tvcodes/tvearn
,
tvcodes/tvearnings
, and 30 more.
from
CNBC.com News
Bristol-Myers Squibb Shares Up 22.3% Since SmarTrend's Buy Recommendation (BMY)
April 24, 2013
from
Comtex SmarTrend® News Briefs
Brystol-Myers Squibbs Preview: Performance Of New Drugs The Key
April 24, 2013
category
Pharmaceuticals
,
Unassigned
from
Trefis
Boehringer anti-clotting pill gains blockbuster status
April 24, 2013
INGELHEIM, Germany, April 24 (Reuters) - Boehringer Ingelheim said its anti-blood-clotting drug Pradaxa reached blockbuster status in 2012, helping the world's largest unlisted drugmaker to an 11.5...
Read More
category
companyNews
from
Reuters: Company News
Daily Trade Flow Review for Bristol-Myers Squibb Company (BMY)
April 24, 2013
NEW YORK (AVAFIN) -- During the last trading session, a new 90-day call record ...
Read More
from
AVAFIN
Bristol-Myers Squibb Co. Moves Up In Market Cap Rank, Passing Union Pacific Corp
April 23, 2013
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Bristol-Myers Squibb Co. (BMY) has taken over the #44 spot from Union Pacific Corp (UNP),...
Read More
category
Stocks
from
Market News Video
UPDATE 1-AbbVie hepatitis C drugs knock out virus at 8 weeks
April 23, 2013
* Bristol-Myers shares up 1.2 percent after promising data
Read More
category
companyNews
from
Reuters: Company News
Vertex Pharma (VRTX) Reports Significant Data from VX-135 in HCV RNA
April 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8270447 for the full story.
Read More
from
StreetInsider.com News Articles
Bristol-Myers oral hepatitis C regimen looks competitive -study
April 23, 2013
* 2 serious side effects likely unconnected to Bristol drugs
Read More
category
companyNews
from
Reuters: Company News
Moody's sees pick-up in pharmaceutical industry M&A in 2013
April 22, 2013
LONDON, April 23 (Reuters) - Cash-rich drug companies are likely to make more acquisitions in 2013 after a thin year for deals in 2012, ratings agency Moody's Investors Service said on Tuesday.
Read More
category
companyNews
from
Reuters: Company News
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here